Status:
RECRUITING
Positive Minds Strong Joints for Knee Osteoarthritis
Lead Sponsor:
Boston University Charles River Campus
Collaborating Sponsors:
Rheumatology Research Foundation
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The aim of this research study is to test the feasibility of a physical and mental health intervention (Positive Minds, Strong Joints or PMSJ) for Black adults with knee osteoarthritis (OA).
Detailed Description
In this feasibility study, at least 20 and up to 40 Black Adults will be enrolled to receive PMSJ intervention. Participants who will take part in this research study will be in it for about 26 weeks....
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age≥50
- BMI ≤ 40 kg/m2
- Self-identify as Black (including African American)
- Knee pain ≥4/10 on a 11 numeric scale over the past week
- Scored 5 or more on either the Patient Health Questionnaire (PHQ-9) and/or the Generalized Anxiety Disorder 7-item Scale (GAD-7)
- Can speak and understand English at a sufficient level to understand the study procedures and informed consent
- Available for study duration
- Able to attend remote sessions
- EXCLUSION CRITERIA
- Knee, hip or ankle replacement
- Intra-articular corticosteroid or hyaluronic acid knee injection within 3 months
- Knee surgery within past 6 months
- Currently receiving or received within 3-months any PT for knee OA
- Currently receiving or received within 3 months any mental health intervention (excluding pharmacologic treatments)
- Planning to initiate physical therapy for joint or low back pain in the next 3months
- Planning to initiate any mental health treatment (excluding pharmacologic treatments) in the next 1 month.
- Systemic inflammatory arthritis (e.g., rheumatoid arthritis)
- Neurologic conditions (e.g., stroke, Parkinson's disease, etc.)
- Contraindications to starting an exercise program.
- Suspected substance abuse
- Lack capacity to consent
- Pregnancy (self-report)
- Participation in another clinical trial for any joint or muscle pain
- Planning for a major surgery in the next 6 months
- Having high risk mental health symptoms (active suicidality, bipolar disorder, mania, psychosis, schizophrenia)
- Receiving chemotherapy or radiation therapy for cancer (except non-melanoma skin cancer)
Exclusion
Key Trial Info
Start Date :
February 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06493903
Start Date
February 17 2025
End Date
December 30 2026
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston University
Boston, Massachusetts, United States, 02215